22 Open vs. minimally invasive radical trachelectomy in early stage cervical cancer: international multicenter irta study results. (18th September 2019)
- Record Type:
- Journal Article
- Title:
- 22 Open vs. minimally invasive radical trachelectomy in early stage cervical cancer: international multicenter irta study results. (18th September 2019)
- Main Title:
- 22 Open vs. minimally invasive radical trachelectomy in early stage cervical cancer: international multicenter irta study results
- Authors:
- Salvo, G
Ramirez, PT
Wu, X
Leitao, M
Mosgaard, BJ
Falconer, H
Perrotta, M
Rendón, G
Kucukmetin, A
Berlev, I
Persson, J
Vieira, M
Cibula, D
Fotopoulou, C
Liu, K
Ribeiro, R
Capilna, ME
Kaidarova, D
Baiocchi, G
Li, X
Li, J
Pedra-Nobre, S
Pálsdóttir, K
Noll, F
Rundle, S
Ulrikh, E
Kocian, R
Saso, S
Hu, Z
Tsunoda, A
Gheorghe, M
Bolatbekova, R
Pitcher, B
Pareja, R
… (more) - Abstract:
- Abstract : Objectives: To compare disease-free survival (DFS) between patients who underwent open (ORT) versus minimally invasive (MIS) radical trachelectomy (RT) [laparoscopic (LRT) or robotic (RRT)]. Methods: Eligibility criteria included: 1) RT and pelvic lymphadenectomy with/without sentinel lymph node mapping, 2) 1/2005 to 12/2017 3) squamous, adenocarcinoma, or adenosquamous histology, 4) stage IA2-IB1, 5) tumors ≤2 cm, 6) 15 or more cases per center. Results: A total of 698 patients [open (n=388) vs. MIS (310)] were included. The median follow-up time was 40.9 months (range, 1–179.1) [MIS 38.6 (range, <1–128.1) vs. open 68.3 (range, <1–200.8) (p<0.001)]. MIS patients had smaller tumors (no visible lesion: 76.8% vs 57.0%, < 1 cm: 1.9% vs. 2.8%, 1–2 cm: 21.3% vs. 40.2%, p<0.001) and lower rates of residual disease (42.9% vs. 56.2% p<0.001). (table 1 ) There were no differences in rates of parametrial involvement (2.1% vs. 1.3% p=0.055), vaginal involvement (0.8% vs. 1.4% p=0.198), positive margins (2.9% vs. 3.5% p=0.766), or positive nodes (7.2% vs. 4.5%, p=4.02). (table 2 ) Patients who underwent open RT had longer hospital stay (6 (1–23) vs 2 (0–24) days, p<0.001) and received more adjuvant therapy (12.7% vs. 5.9%, p=0.003). MIS patients had more readmissions (11.0% vs. 1.8%, p<0.001) and reoperations (4.8% vs. 1.5%, p=0.01). There was no difference in recurrence rate (6.4% vs. 5.7%, p=0.7492), DFS (p=0.46) or OS (p=0.91) between MIS and open surgical approachesAbstract : Objectives: To compare disease-free survival (DFS) between patients who underwent open (ORT) versus minimally invasive (MIS) radical trachelectomy (RT) [laparoscopic (LRT) or robotic (RRT)]. Methods: Eligibility criteria included: 1) RT and pelvic lymphadenectomy with/without sentinel lymph node mapping, 2) 1/2005 to 12/2017 3) squamous, adenocarcinoma, or adenosquamous histology, 4) stage IA2-IB1, 5) tumors ≤2 cm, 6) 15 or more cases per center. Results: A total of 698 patients [open (n=388) vs. MIS (310)] were included. The median follow-up time was 40.9 months (range, 1–179.1) [MIS 38.6 (range, <1–128.1) vs. open 68.3 (range, <1–200.8) (p<0.001)]. MIS patients had smaller tumors (no visible lesion: 76.8% vs 57.0%, < 1 cm: 1.9% vs. 2.8%, 1–2 cm: 21.3% vs. 40.2%, p<0.001) and lower rates of residual disease (42.9% vs. 56.2% p<0.001). (table 1 ) There were no differences in rates of parametrial involvement (2.1% vs. 1.3% p=0.055), vaginal involvement (0.8% vs. 1.4% p=0.198), positive margins (2.9% vs. 3.5% p=0.766), or positive nodes (7.2% vs. 4.5%, p=4.02). (table 2 ) Patients who underwent open RT had longer hospital stay (6 (1–23) vs 2 (0–24) days, p<0.001) and received more adjuvant therapy (12.7% vs. 5.9%, p=0.003). MIS patients had more readmissions (11.0% vs. 1.8%, p<0.001) and reoperations (4.8% vs. 1.5%, p=0.01). There was no difference in recurrence rate (6.4% vs. 5.7%, p=0.7492), DFS (p=0.46) or OS (p=0.91) between MIS and open surgical approaches (figure 1 ). Conclusions: Surgical approach in radical trachelectomy for low-risk cervical cancer was not associated with differences in recurrence rates or survival. MIS had worse perioperative outcomes. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 3
- Issue Display:
- Volume 29, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 3
- Issue Sort Value:
- 2019-0029-0003-0000
- Page Start:
- A13
- Page End:
- A14
- Publication Date:
- 2019-09-18
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-IGCS.22 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19725.xml